Antispasmodics Drugs Market 2027 By Product Type, Route of Administration, Distribution Channel | The Insight Partners

Antispasmodics Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Prednisolone, Triamcinolone, Prednisone, Methylprednisolone, Dexamethasone); Route of Administration (Intramuscular, Intra-articular, Intravenous, Epidural); Distribution Channel (Hospital pharmacy, Specialty clinics, Retail pharmacy & drug stores, Others)

Report Code: TIPRE00015270 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Antispasmodic drugs relax the smooth muscles of the urinary bladder. By exerting a direct spasmolytic action on the bladder's smooth muscle, antispasmodic drugs have been reported to increase bladder capacity and effectively decrease or eliminate urge incontinence. The adverse-effect profile of antispasmodic drugs is similar to that of anticholinergic agents. These drugs may impair the patient's ability to perform activities requiring mental alertness and physical coordination. Drinking alcohol and using sedatives in combination with these antispasmodic drugs is contraindicated.

MARKET DYNAMICS

Factors driving the growth of the antispasmodics drugs market are the growing prevalence of irritable bowel syndrome, coupled with high patient awareness level and improvement in treatment. However, the product recalls is expected to hamper the growth of the market. Moreover, adoption of sedentary life style and rising investments by major market players in antispasmodics drugs is anticipated to boost the market growth.

MARKET SCOPE

The "Antispasmodics Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of antispasmodics drugs market with detailed market segmentation by drugs, indication, route of administration, end-users and distribution channel. The antispasmodics drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in antispasmodics drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The antispasmodics drugs market is segmented on the basis of drugs, indication, route of administration, end-user and distribution channel. Based on drugs, the market is segmented as Loperamide hydrochloride, Dicyclomine hydrochloride, and others. On the basis of indication, the market is categorized as irritable bowel syndrome , stomach cramps, and others. On the basis of route of administration, the market is categorized as oral, sublingual, injectable, and others. On the basis of end-user, the market is categorized as hospitals, homecare, speciality centres, and others. Based on distribution channel, the market is segmented as hospital pharmacy, online pharmacy, and retail pharmacy.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the antispasmodics drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antispasmodics drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting antispasmodics drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antispasmodics drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the antispasmodics drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from antispasmodics drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for antispasmodics drugs in the global market. Below mentioned is the list of few companies engaged in the antispasmodics drugs market.

The report also includes the profiles of key players in antispasmodics drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Allergan
  •  Hikma Pharmaceuticals
  •  Lannett
  •  Mylan N.V.
  •  Nexus Pharmaceuticals
  •  Akorn Incorporated
  •  Aurobindo Pharma
  •  Daiichi Sankyo, Inc
  •  Fresenius Kabi Ag
  •  Shanghai Fosun Pharmaceutical (Group) Co., Ltd
  •  SunGen Pharma LLC
  •  Others

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Softgel Capsules Market - By Product Type
1.3.2 Softgel Capsules Market - By Raw Material
1.3.3 Softgel Capsules Market - By Application
1.3.4 Softgel Capsules Market - By End User
1.3.5 Softgel Capsules Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SOFTGEL CAPSULES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SOFTGEL CAPSULES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SOFTGEL CAPSULES MARKET - GLOBAL MARKET ANALYSIS
6.1. SOFTGEL CAPSULES - GLOBAL MARKET OVERVIEW
6.2. SOFTGEL CAPSULES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. SOFTGEL CAPSULES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. GELATIN SOFTGEL CAPSULES
7.3.1. Overview
7.3.2. Gelatin Softgel Capsules Market Forecast and Analysis
7.4. VEGETARIAN SOFTGEL CAPSULES
7.4.1. Overview
7.4.2. Vegetarian Softgel Capsules Market Forecast and Analysis
8. SOFTGEL CAPSULES MARKET - REVENUE AND FORECASTS TO 2027 - RAW MATERIAL
8.1. OVERVIEW
8.2. RAW MATERIAL MARKET FORECASTS AND ANALYSIS
8.3. TYPE-A GELATIN (PORK SKIN)
8.3.1. Overview
8.3.2. Type-A Gelatin (Pork Skin) Market Forecast and Analysis
8.4. TYPE-B GELATIN (ANIMAL BONES & CALF SKIN)
8.4.1. Overview
8.4.2. Type-B Gelatin (Animal Bones & Calf Skin) Market Forecast and Analysis
8.5. FISH BONE GELATIN
8.5.1. Overview
8.5.2. Fish Bone Gelatin Market Forecast and Analysis
8.6. HYDROXY PROPYL METHYL CELLULOSE (HPMC)
8.6.1. Overview
8.6.2. Hydroxy Propyl Methyl Cellulose (HPMC) Market Forecast and Analysis
8.7. STARCH MATERIAL
8.7.1. Overview
8.7.2. Starch Material Market Forecast and Analysis
8.8. PULLULAN
8.8.1. Overview
8.8.2. Pullulan Market Forecast and Analysis
9. SOFTGEL CAPSULES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ANTACID & ANTIFLATULENT PREPARATIONS
9.3.1. Overview
9.3.2. Antacid & Antiflatulent Preparations Market Forecast and Analysis
9.4. ANTIANEMIC PREPARATIONS (HEMATENIC PREPARATIONS)
9.4.1. Overview
9.4.2. Antianemic Preparations (Hematenic Preparations) Market Forecast and Analysis
9.5. ANTI-INFLAMMATORY DRUGS
9.5.1. Overview
9.5.2. Anti-inflammatory Drugs Market Forecast and Analysis
9.6. ANTIBIOTIC & ANTIBACTERIAL DRUGS
9.6.1. Overview
9.6.2. Antibiotic & Antibacterial Drugs Market Forecast and Analysis
9.7. COUGH & COLD PREPARATIONS
9.7.1. Overview
9.7.2. Cough & Cold Preparations Market Forecast and Analysis
9.8. CARDIOVASCULAR THERAPY DRUGS
9.8.1. Overview
9.8.2. Cardiovascular Therapy Drugs Market Forecast and Analysis
9.9. VITAMIN AND DIETARY SUPPLEMENTS
9.9.1. Overview
9.9.2. Vitamin and Dietary Supplements Market Forecast and Analysis
9.10. OTHERS
9.10.1. Overview
9.10.2. Others Market Forecast and Analysis
10. SOFTGEL CAPSULES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical Companies Market Forecast and Analysis
10.4. NUTRACEUTICAL COMPANIES
10.4.1. Overview
10.4.2. Nutraceutical Companies Market Forecast and Analysis
10.5. COSMECEUTICAL COMPANIES
10.5.1. Overview
10.5.2. Cosmeceutical Companies Market Forecast and Analysis
10.6. CONTRACT MANUFACTURING ORGANIZATIONS
10.6.1. Overview
10.6.2. Contract Manufacturing Organizations Market Forecast and Analysis
11. SOFTGEL CAPSULES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Softgel Capsules Market Overview
11.1.2 North America Softgel Capsules Market Forecasts and Analysis
11.1.3 North America Softgel Capsules Market Forecasts and Analysis - By Product Type
11.1.4 North America Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.1.5 North America Softgel Capsules Market Forecasts and Analysis - By Application
11.1.6 North America Softgel Capsules Market Forecasts and Analysis - By End User
11.1.7 North America Softgel Capsules Market Forecasts and Analysis - By Countries
11.1.7.1 United States Softgel Capsules Market
11.1.7.1.1 United States Softgel Capsules Market by Product Type
11.1.7.1.2 United States Softgel Capsules Market by Raw Material
11.1.7.1.3 United States Softgel Capsules Market by Application
11.1.7.1.4 United States Softgel Capsules Market by End User
11.1.7.2 Canada Softgel Capsules Market
11.1.7.2.1 Canada Softgel Capsules Market by Product Type
11.1.7.2.2 Canada Softgel Capsules Market by Raw Material
11.1.7.2.3 Canada Softgel Capsules Market by Application
11.1.7.2.4 Canada Softgel Capsules Market by End User
11.1.7.3 Mexico Softgel Capsules Market
11.1.7.3.1 Mexico Softgel Capsules Market by Product Type
11.1.7.3.2 Mexico Softgel Capsules Market by Raw Material
11.1.7.3.3 Mexico Softgel Capsules Market by Application
11.1.7.3.4 Mexico Softgel Capsules Market by End User
11.1.7.4 US Softgel Capsules Market
11.1.7.4.1 US Softgel Capsules Market by Product Type
11.1.7.4.2 US Softgel Capsules Market by Raw Material
11.1.7.4.3 US Softgel Capsules Market by Application
11.1.7.4.4 US Softgel Capsules Market by End User
11.2. EUROPE
11.2.1 Europe Softgel Capsules Market Overview
11.2.2 Europe Softgel Capsules Market Forecasts and Analysis
11.2.3 Europe Softgel Capsules Market Forecasts and Analysis - By Product Type
11.2.4 Europe Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.2.5 Europe Softgel Capsules Market Forecasts and Analysis - By Application
11.2.6 Europe Softgel Capsules Market Forecasts and Analysis - By End User
11.2.7 Europe Softgel Capsules Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Softgel Capsules Market
11.2.7.1.1 Germany Softgel Capsules Market by Product Type
11.2.7.1.2 Germany Softgel Capsules Market by Raw Material
11.2.7.1.3 Germany Softgel Capsules Market by Application
11.2.7.1.4 Germany Softgel Capsules Market by End User
11.2.7.2 France Softgel Capsules Market
11.2.7.2.1 France Softgel Capsules Market by Product Type
11.2.7.2.2 France Softgel Capsules Market by Raw Material
11.2.7.2.3 France Softgel Capsules Market by Application
11.2.7.2.4 France Softgel Capsules Market by End User
11.2.7.3 Italy Softgel Capsules Market
11.2.7.3.1 Italy Softgel Capsules Market by Product Type
11.2.7.3.2 Italy Softgel Capsules Market by Raw Material
11.2.7.3.3 Italy Softgel Capsules Market by Application
11.2.7.3.4 Italy Softgel Capsules Market by End User
11.2.7.4 Spain Softgel Capsules Market
11.2.7.4.1 Spain Softgel Capsules Market by Product Type
11.2.7.4.2 Spain Softgel Capsules Market by Raw Material
11.2.7.4.3 Spain Softgel Capsules Market by Application
11.2.7.4.4 Spain Softgel Capsules Market by End User
11.2.7.5 United Kingdom Softgel Capsules Market
11.2.7.5.1 United Kingdom Softgel Capsules Market by Product Type
11.2.7.5.2 United Kingdom Softgel Capsules Market by Raw Material
11.2.7.5.3 United Kingdom Softgel Capsules Market by Application
11.2.7.5.4 United Kingdom Softgel Capsules Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Softgel Capsules Market Overview
11.3.2 Asia-Pacific Softgel Capsules Market Forecasts and Analysis
11.3.3 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By Product Type
11.3.4 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.3.5 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Softgel Capsules Market
11.3.7.1.1 Australia Softgel Capsules Market by Product Type
11.3.7.1.2 Australia Softgel Capsules Market by Raw Material
11.3.7.1.3 Australia Softgel Capsules Market by Application
11.3.7.1.4 Australia Softgel Capsules Market by End User
11.3.7.2 China Softgel Capsules Market
11.3.7.2.1 China Softgel Capsules Market by Product Type
11.3.7.2.2 China Softgel Capsules Market by Raw Material
11.3.7.2.3 China Softgel Capsules Market by Application
11.3.7.2.4 China Softgel Capsules Market by End User
11.3.7.3 India Softgel Capsules Market
11.3.7.3.1 India Softgel Capsules Market by Product Type
11.3.7.3.2 India Softgel Capsules Market by Raw Material
11.3.7.3.3 India Softgel Capsules Market by Application
11.3.7.3.4 India Softgel Capsules Market by End User
11.3.7.4 Japan Softgel Capsules Market
11.3.7.4.1 Japan Softgel Capsules Market by Product Type
11.3.7.4.2 Japan Softgel Capsules Market by Raw Material
11.3.7.4.3 Japan Softgel Capsules Market by Application
11.3.7.4.4 Japan Softgel Capsules Market by End User
11.3.7.5 South Korea Softgel Capsules Market
11.3.7.5.1 South Korea Softgel Capsules Market by Product Type
11.3.7.5.2 South Korea Softgel Capsules Market by Raw Material
11.3.7.5.3 South Korea Softgel Capsules Market by Application
11.3.7.5.4 South Korea Softgel Capsules Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Softgel Capsules Market Overview
11.4.2 Middle East and Africa Softgel Capsules Market Forecasts and Analysis
11.4.3 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By Product Type
11.4.4 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.4.5 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Softgel Capsules Market
11.4.7.1.1 South Africa Softgel Capsules Market by Product Type
11.4.7.1.2 South Africa Softgel Capsules Market by Raw Material
11.4.7.1.3 South Africa Softgel Capsules Market by Application
11.4.7.1.4 South Africa Softgel Capsules Market by End User
11.4.7.2 Saudi Arabia Softgel Capsules Market
11.4.7.2.1 Saudi Arabia Softgel Capsules Market by Product Type
11.4.7.2.2 Saudi Arabia Softgel Capsules Market by Raw Material
11.4.7.2.3 Saudi Arabia Softgel Capsules Market by Application
11.4.7.2.4 Saudi Arabia Softgel Capsules Market by End User
11.4.7.3 U.A.E Softgel Capsules Market
11.4.7.3.1 U.A.E Softgel Capsules Market by Product Type
11.4.7.3.2 U.A.E Softgel Capsules Market by Raw Material
11.4.7.3.3 U.A.E Softgel Capsules Market by Application
11.4.7.3.4 U.A.E Softgel Capsules Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Softgel Capsules Market Overview
11.5.2 South and Central America Softgel Capsules Market Forecasts and Analysis
11.5.3 South and Central America Softgel Capsules Market Forecasts and Analysis - By Product Type
11.5.4 South and Central America Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.5.5 South and Central America Softgel Capsules Market Forecasts and Analysis - By Application
11.5.6 South and Central America Softgel Capsules Market Forecasts and Analysis - By End User
11.5.7 South and Central America Softgel Capsules Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Softgel Capsules Market
11.5.7.1.1 Brazil Softgel Capsules Market by Product Type
11.5.7.1.2 Brazil Softgel Capsules Market by Raw Material
11.5.7.1.3 Brazil Softgel Capsules Market by Application
11.5.7.1.4 Brazil Softgel Capsules Market by End User
11.5.7.2 Argentina Softgel Capsules Market
11.5.7.2.1 Argentina Softgel Capsules Market by Product Type
11.5.7.2.2 Argentina Softgel Capsules Market by Raw Material
11.5.7.2.3 Argentina Softgel Capsules Market by Application
11.5.7.2.4 Argentina Softgel Capsules Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SOFTGEL CAPSULES MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Rest of the World
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. SOFTGEL CAPSULES MARKET, KEY COMPANY PROFILES
14.1. AENOVA GROUP GMBH
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. HUNAN ER-KANG PHARMACEUTICAL CO., LTD
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. CAPSUGEL
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. FUJI CAPSULE CO., LTD.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. SIRIO PHARMA COMPANY LIMITED
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. CAPTEK SOFTGEL INTERNATIONAL INC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. CATALENT, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. EUROCAPS LTD (PART OF DCC PLC)
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. GUANGDONG YICHAO BIOLOGICAL CO., LTD
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. ELNOVA PHARMA
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
14.11. OTHERS
14.11.1. Key Facts
14.11.2. Business Description
14.11.3. Products and Services
14.11.4. Financial Overview
14.11.5. SWOT Analysis
14.11.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Allergan
2. Hikma Pharmaceuticals
3. Lannett
4. Mylan N.V.
5. Nexus Pharmaceuticals
6. Akorn Incorporated
7. Aurobindo Pharma
8. Daiichi Sankyo, Inc
9. Fresenius Kabi Ag
10. Shanghai Fosun Pharmaceutical (Group) Co., Ltd
11. SunGen Pharma LLC
TIPRE00015270
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking